Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

News Briefs: 23andMe’s Mea Culpa; FDA Reaches Settlement With J&J; Meaningful Use Delay

This article was originally published in The Gray Sheet

Executive Summary

Genetic testing firm 23andMe has stopped providing its genetic tests to consumers, following a warning letter from FDA. The agency has reached a $1.25 million settlement with Johnson & Johnson’s Advanced Sterilization Products group. HHS agencies announced delay in health IT meaningful use implementation. More news.

Advertisement

Related Content

Active Months Ahead For mHealth Regulatory Policymaking
Active Months Ahead For mHealth Regulatory Policymaking
Lawmakers Want HIPAA Data Access Rules Amended To Encourage Consumer ‘Shopping’ For Diagnostics
Questions Remain On Incorporating UDIs Into Health Care System
FDA Comes Down Hard On 23andMe, Putting Consumer-Directed Genetic Testing On Notice
Quest Enters Market For BRCA Gene Testing
Diagnostic Companies Rush To Test Formerly Off-Limit Genes
Exact Sciences Completes Modular PMA For Cologuard
Regulatory News In Brief
Prostate Cancer Radiation Comparisons Support IMRT, Question Proton Therapy

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT032640

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel